Energy-based Therapeutics

Energy-based Therapeutics

Global Energy-based Therapeutics Market to Reach US$9.5 Billion by 2030

The global market for Energy-based Therapeutics estimated at US$7.4 Billion in the year 2023, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Light-based Technology segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 7.0% CAGR

The Energy-based Therapeutics market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Energy-Based Therapeutics Market - Trends & Drivers Summarized

Energy-based therapeutics is a medical field that utilizes various energy forms to remove pathological tissues and modify healthy tissues for therapeutic purposes. This includes technologies like microwave, radiofrequency, hydro-mechanical, cryotherapy, thermal, and ultrasound. These therapies are used to destroy or change tissues and have broad applications in different medical and aesthetic procedures. Common uses include general surgeries for gynecology and lithotripsy, ophthalmic surgeries for glaucoma and cataract treatments, and aesthetic surgeries for issues such as acne and pigmentation reduction. Both invasive and non-invasive methods are employed, with the latter gaining significant traction due to their less intrusive nature and quicker recovery times, making these therapies popular worldwide.

The growth of the energy-based therapeutics market is driven by several factors, foremost among them being the rising preference for minimally invasive surgeries. These procedures, characterized by shorter recovery periods and reduced risks, have become highly attractive to patients. The preference for minimally invasive procedures is driving the demand for energy-based surgical instruments and techniques. Additionally, advancements in aesthetic medicine have led to increased adoption of anti-aging treatments and energy-based aesthetic surgeries, which are not only effective but also relatively affordable. The shift from invasive to non-invasive procedures is contributing to market growth. Moreover, the trend of physician-owned ambulatory surgical centers, which offer outpatient treatments, is creating significant growth opportunities, as most energy-based procedures do not require hospitalization.

The future of energy-based therapeutics market will be influenced by ongoing technological advancements and a growing demand for non-invasive procedures. Innovations in minimally invasive laser therapies and precise targeting through advanced imaging technologies have significantly improved treatment efficacy and patient outcomes. The integration of artificial intelligence (AI) and the Internet of Things (IoT) in therapeutic devices has further personalized treatment options, optimizing energy delivery to meet individual patient needs. Additionally, there is an increasing application of energy-based therapies in fields such as oncology and cardiology, driven by their effectiveness in providing targeted treatments with minimal side effects. The aging global population and the rising prevalence of chronic diseases are also fueling market growth, as these conditions often require the precise and targeted treatment approaches that energy-based therapies can provide. This broad and expanding market continues to evolve, with regions like North America and Europe leading in adoption, while Asia-Pacific shows significant growth potential.

Select Competitors (Total 45 Featured) -

• Alcon Switzerland SA
• Alna-Medicalsystem AG and Co.KG
• AngioDynamics, Inc.
• ATRICURE, Inc.
• BIOLASE, Inc.
• Biolitec Holding GmbH & Co KG
• Boston Scientific Corporation
• Candela Corporation
• Cutera, Inc.
• Cynosure LLC
• Dornier MedTech GmbH
• EDAP TMS SA
• LIGHTMED
• Lumenis Be Ltd.
• Medtronic;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.